Materials and methods
Sepharose CL-2B, Blue Sepharose CL-6B, Sephadex G-100, and human a, proteinase inhibitor antisera were supplied by Pharmacia (South Seas) Pty Ltd, Sydney, Australia. Hyaluronidase (from Streptomyces hyalurolyticus (EC 4.2.99.1.)), human intera-trypsin inhibitor antisera, and Aquacide II were purchased from Calbiochem-Behring (Australia) Pty Ltd, Kingsgrove, NSW, Australia. Human haptoglobin antisera were obtained from Silenus Labs, Pty Ltd, Dandenong, Vic, Australia. Human haptoglobin, a1 proteinase inhibitor, trypsin type XIII: TPCK treated from bovine pancreas, N-acarbobenzoxy-L-arginine-p-nitroanilide HCl, and phorbol 12-myristate 13-acetate (PMA) were obtained from Sigma Chemical Co, St Louis, MO, USA. Before use the a1 proteinase inhibitor was further purified on Blue Sepharose CL-6B and Sephadex G-100 columns. Inter-a-trypsin inhibitor was isolated and purified from human serum according to the method of Salier et al. 8 All other chemicals used were of analytical grade.
SOURCES OF HYALURONIC ACID (HA)
All the HA preparations used in this investigation were isolated from pathological human synovial fluids that had been aspirated aseptically from the joints of patients attending arthritis clinics at this hospital or the North Shore Medical Centre, St Leonards, NSW. Normal SF were derived from cadaveric joints and collected with six hours of death at the time of necropsy at the Royal North Shore Hospital. The cadaveric SF were only used if the pathology and clinical history showed no evidence of joint diseases. The pathological fluids were classified by one of us (PMB) as gouty, RA, or osteoarthritic using standard clinical/laboratory criteria. The particulate material and cellular content of all fluids were removed by centrifugation at 1500 g for 15 minutes. The supernatants were collected and maintained at 4°C until used. In most instances, however, they were applied to the Sepharose CL-2B column within an hour of aspiration from the joints.
SEPARATION OF HA FROM NON-BOUND SYNOVIAL PROTEINS
The synovial fluids were chromatographed individually on a precalibrated Sepaharose CL-2B column (2x90 cm) maintained at 4°C. The eluting buffer was 10 mM phosphate, 0*15 M NaCl pH 7-2, and 2-5 ml fractions were collected at a flow rate of 10 ml/h. The were monitored for hexuronic acid9 at 520 nm (~) and for protein'0 at 750 nm (--) as described in 'Materials and methods'. Note, for the RA synovialfluids, the protein (hatched) firmly associated with the hexuronic acid containingfractions that eluted in the void volume (Vo) ofthe column. group.bmj.com on June 23, 2017 -Published by http://ard.bmj.com/ Downloaded from graphy of RA SF was completely removed by digestion with proteinase free Streptomyces hyaluronidase. These digests, when subjected to SDS-PAGE using the method of Weber and Osborn,12 showed four major bands corresponding in mobility to a, proteinase inhibitor, inter-a-trypsin inhibitor, and haptoglobin (Fig. 2) Interaction of hyaluronic acid with synovial proteins 381 raised against the acute phase proteins, a, proteinase inhibitor, inter-a-trypsin inhibitor, and haptoglobin, produced precipitin lines with the HA bound proteins from RA SF (Fig. 3) . Antisera to other acute phase proteins, such as C reactive protein, caeruloplasmin, a2 macroglobulin, etc, were found to be inactive against the HA bound proteins using this immunological assay.
Relative amounts of the individual acute phase proteins associated with HA, in the total Vo fractions of RA fluids, were calculated from the diameters of the precipitin rings produced against various concentrations of each standard protein antigen in the radial immunodiffusion assay (Fig. 4) In these experiments HA in the Vo fractions from chromatography of normal SF was incubated separately with each of the three acute phase proteins identified as binding to HA in the RA synovial fluids. The presence of bound proteins in the Vo fractions was determined by UV absorption at 280 nm and by the trypsin inhibitory assay for a, proteinase inhibitor and inter-a-trypsin inhibitor. '8 Binding of these three acute phase proteins to protein 'free' HA was demonstrable both by the appearance of protein positive material eluting at Vo and by the inhibitory activity against trypsin (Fig. 5) . It was noted, however, that the trypsin inhibitory activity of a, proteinase inhibitor when bound to HA was significantly less than when unbound using protein as a marker of inhibitor concentration (Fig. 5) . The levels of the three acute phase proteins associated with HA when prepared by this in vitro procedure were comparable with those determined for HA of fluids derived from RA joints.
EFFECTS OF ODFR ON HA-PROTEIN COMPLEXES
Exposure of high molecular weight HA with low protein content (<1%) to an ODFR flux generated by the Fe++ autoxidation system'5 16 or PMA stimulated PMNL'9 caused depolymerisation of HA, as shown by the inclusion of hexuronate positive material on the Sepharose CL-2B gel. Identical experiments conducted with equivalent amounts of HA derived from RA fluids in which the Vo fraction protein content was >7% of total were less degraded (Fig. 6) .
In an attempt to identify which of the three acute phase proteins bound to HA in RA fluids was the most effective in protecting HA against ODFR degradation the respective in vitro prepared HAprotein complexes were exposed to an Fe++ autoxidation free radical flux. The results of these experiments are shown in Fig. 7 , where it is evident that under the vigorous conditions used a, proteinase inhibitor was ineffective at preventing degradation of HA, whereas haptoglobin and inter-a-trypsin inhibitor showed some protection. Fraction Number Fig. 6 Sepharose CL-2B chromatograms ofsynovial fluid HA from normal and RA joints after exposure to (A) 30 (--) as previously described.
noting that once bound to HA, inter-a1-trypsin inhibitor conserved its antiproteinase activity but that of a1 proteinase inhibitor was substantially reduced, at least as determined by the assay conditions used here (Figs 5 and 7) . Thus it is tempting to speculate that the conformation of a1 proteinase was altered on interaction with HA. Alternatively, binding to HA may have masked the active site of the inhibitor. Although it was possible to form complexes in vitro with non-degraded HA isolated from normal SF and the three acute phase proteins described above, we have not excluded the possibility that such complexes might be formed in vivo with HA modified structurally by its interaction with free radicals. Despite this uncertainty it appears that complex formation in vivo arises as a consequence of the high levels of the acute phase proteins present in SFs of RA joints, the concentration of these proteins being low in normal SFs.20 21 The identity of the smaller amounts of protein associated with osteoarthritic and gouty fluids was not established in the present study, but it is likely that they include one or all of the acute phase proteins found associated with HA in RA fluids. These proteins may have entered the osteoarthritic joint during previous inflammatory episodes. Sandson A consistent feature of the chromatographic profiles of HA from the inflamed SF investigated in our study was the exclusion of most of the material from the Sepharose CL-2B column (see Fig. 1B ). This indicated that most HA in SF of inflamed joints had a molecular weight greater than 1 x 106 daltons. A recent report by Dahl et al, who used high porosity gels, showed that the molecular weight of HA declines, on average, from 7-0x106 in normal SF to about 4-8x 106 in SF from patients with RA.4 This study also indicated that at least 30% of the HA present in the RA SF was of high molecular weight. This group suggested that although depolymerisation of HA occurs within the inflamed joint, the dilution of SF by the plasma dialysate was largely responsible for the frequently observed decline in viscosity. This conclusion may have to be modified in the light of present studies as the high molecular weight proteins that bind to HA in inflamed joints could also alter the hydrodynamic size and rheological properties of the HA preparations examined by gel permeation From the present studies we concluded that certain acute phase proteins diffusing into the joints as a consequence of synovial inflammation may, in addition to some resident proteins, serve a useful role in protecting HA from degradation by ODFR and hydrogen peroxide. Furthermore, as these electron rich species are also known to degrade basement membranes and components of the cartilage matrix36 37 
